VOLPARA HEALTH TECHNOLOGIES LIMITED (VHT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

VHT - VOLPARA HEALTH TECHNOLOGIES LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: March
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.28
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.12

23 Feb
2024

0.000

OPEN

$1.12

0.000

HIGH

$1.13

382,785

LOW

$1.12

TARGET
$1.15 2.7% upside
OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS
VHT: 1
Title FY24
Forecast
FY25
Forecast
EPS (cps) - 2.0 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-3.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx31.9 M
Book Value Per Share xxxxxxxxxxxxxxx18.8
Net Operating Cash Flow xxxxxxxxxxxxxxx-3.5 M
Net Profit Margin xxxxxxxxxxxxxxx-27.99 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-17.60 %
Return on Invested Capital xxxxxxxxxxxxxxx-17.06 %
Return on Assets xxxxxxxxxxxxxxx-11.99 %
Return on Equity xxxxxxxxxxxxxxx-17.60 %
Return on Total Capital xxxxxxxxxxxxxxx-22.36 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-3.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx20 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx12 M
Price To Book Value xxxxxxxxxxxxxxx4.03

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx2.3 M
Capex % of Sales xxxxxxxxxxxxxxx7.34 %
Cost of Goods Sold xxxxxxxxxxxxxxx7 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx36 M
Research & Development xxxxxxxxxxxxxxx16 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

15/12/2023

3

Downgrade to Hold from Buy

$1.15

2.68%

Volpara Health Technologies has received an all cash takeover bid from Korean company Lunit at $1.15 per share, an offer that the Board finds in the best interests of shareholders to accept. The company's two largest shareholders have indicated they will vote in favour of the offer.

Bell Potter points out the bid is a 47.4% premium to the previous closing price, valuing Volpara Health Technologies at $296m. The broker expects a counter bid is unlikely, feeling an absence of significant scale and rapid growth will be barriers to a competing bid.

The rating is downgraded to Hold from Buy and the target price increases to $1.15 from 85 cents.

FORECAST
Bell Potter forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -2.13 cents.
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -1.11 cents.

VHT STOCK CHART